Michael John Tomsicek - Insider Trading & Ownership

Location
28 Overlook Drive, Bedford, MA
Summary
The estimated net worth of Michael John Tomsicek is at least $118K dollars as of June 17, 2025. Michael John Tomsicek is the Chief Financial Officer of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $118K.
Signature
/s/ Adam D. Levy, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Michael John Tomsicek

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRSP CRISPR Therapeutics AG Chief Financial Officer $118K Aug 6, 2021
ACRV Acrivon Therapeutics, Inc. Director Jun 13, 2025
MIST Milestone Pharmaceuticals Inc. Director Jun 10, 2025

Insider Transactions Reported by Michael John Tomsicek:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.